Anika Therapeutics, Inc.
ANIKNasdaqCIK 898437HealthcareFiscal year ends Dec 31
Reports and events: 267 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-2916:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001171843-26-005012 |
| 2026-07-2907:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004977 |
| 2026-07-1417:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001171843-26-004635 |
| 2026-06-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-004253 |
| 2026-04-3019:47 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001171843-26-002852 |
| 2026-04-2907:20 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-002799 |
| 2026-04-2816:47 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001140361-26-017488 |
| 2026-03-0318:49 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001171843-26-001275 |
| 2026-02-2607:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-073401 |
| 2026-01-2719:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-000511 |
| 2026-01-0816:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-007655 |
| 2025-11-2109:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-005133 |
| 2025-11-0516:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001171843-25-007032 |
| 2025-11-0507:20 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007003 |
| 2025-07-3016:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001171843-25-004826 |
| 2025-07-3007:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004810 |
| 2025-07-3007:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004809 |
| 2025-06-2417:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-004062 |
| 2025-05-0914:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001171843-25-003019 |
| 2025-05-0907:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003005 |
| 2025-04-2817:26 ET | DEF 14A | Proxy statementPeriod 2025-06-20 | 0001140361-25-016082 |
| 2025-04-1016:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-002148 |
| 2025-03-1718:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001171843-25-001486 |
| 2025-03-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001437 |
| 2025-03-1108:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-001388 |
| 2024-11-0416:41 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001171843-24-005993 |
| 2024-10-3107:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005923 |
| 2024-10-3107:16 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005922 |
| 2024-08-0817:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001171843-24-004615 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004607 |
| 2024-07-1116:15 ET | 8-K | 5.07 Shareholder vote results | 0001171843-24-003900 |
| 2024-06-1117:05 ET | DEF 14A | Proxy statementPeriod 2024-07-09 | 0001193125-24-159219 |
| 2024-05-3016:31 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-24-003936 |
| 2024-05-2817:04 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003136 |
| 2024-05-0817:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001171843-24-002682 |
| 2024-05-0816:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-24-002673 |
| 2024-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002672 |
| 2024-04-2608:48 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001171843-24-002274 |
| 2024-03-1512:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001171843-24-001380 |
| 2024-03-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001322 |
| 2024-03-0619:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-24-002242 |
| 2024-02-2609:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-24-000972 |
| 2023-11-0317:41 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001171843-23-006687 |
| 2023-11-0216:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006678 |
| 2023-09-2107:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-005813 |
| 2023-09-1106:01 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-23-004717 |
| 2023-08-1708:00 ET | SC 13D | Ownership report, active investor | 0000902664-23-004496 |
| 2023-08-0817:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001171843-23-005114 |
| 2023-08-0816:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005107 |
| 2023-06-2116:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-23-004058 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.